Company Filing History:
1 out of 10 
1 out of 850 
1 out of 832,912 Years Active: 2001-2006
Title: The Innovative Contributions of Daniel E. Levy
Introduction
Daniel E. Levy is a notable inventor based in San Carlos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 3 patents to his name, Levy's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Levy's latest patents include innovative compounds that are designed for therapeutic use. One of his notable inventions is the 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds. These compounds are characterized by a specific formula, wherein A, J, and L can be either a direct link or a divalent linking group. They are particularly useful in the treatment of thrombosis. Another significant patent involves adenine-based inhibitors of adenylyl cyclase, which includes pharmaceutical compositions and methods of use. This invention relates to derivatives and analogues of adenine that can inhibit adenylyl cyclase activity, providing a method for preventing and treating fibroproliferative vasculopathy following vascular injuries or surgical operations. Additionally, this patent outlines a method for measuring the inhibition of adenylyl cyclase activity and offers a treatment approach for congestive heart failure.
Career Highlights
Throughout his career, Daniel E. Levy has worked with various companies, including Photogenesis, Inc. His innovative spirit and dedication to research have led to the development of valuable pharmaceutical compounds that address significant health challenges.
Collaborations
Levy has collaborated with notable individuals in his field, including Robert M. Scarborough and Mark Stephen Smyth. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Daniel E. Levy's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work in developing compounds for treating thrombosis and other medical conditions highlights the importance of innovation in addressing health challenges.